Response to Comments: Non-Invasive Vascular Studies

This response documents an expansion of coverage in the LCD to include non-invasive vascular studies for evaluation of Arterial Fibromuscular Dysplasia (ICD-10 I77.3). No other LCD provisions, limitations, documentation requirements, or frequency limits were changed by this response; refer to the underlying LCD for detailed criteria and existing exclusions.

"Non-invasive vascular studies are covered to evaluate Arterial Fibromuscular Dysplasia (ICD-10: I77."

Sign up to see full coverage criteria, indications, and limitations.